Verition Fund Management Reduces $1M in Axon Enterprise, Inc. ($AXON)

Verition Fund Management reduced its holdings in Axon Enterprise by 8.1% as of May 15, 2026.

Key Points

  • Verition Fund Management reduced its stake in Axon Enterprise by 1,843 shares, an 8.1% decrease, leaving 21,033 shares valued at $10.7 million.
  • Axon Enterprise has a market cap of $37.5 billion and a P/E ratio of 189, with shares trading around $510.60 on Tuesday.
  • Insiders, including the CEO and President, sold shares in early June, while analysts like Citizens reiterated a buy rating with a $700 target.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Verition Fund Management has trimmed its position in Axon Enterprise, Inc. (NasdaqGS: AXON), reducing its holdings by 1,843 shares. This represents an 8.1% decrease, leaving the fund with 21,033 shares valued at approximately $10.7 million as of May 15, 2026. The filing reflects holdings during the reporting period and may not indicate the fund's current position.

13F track record

Verition Fund Management vs. the S&P 500

YTD return +15.40% hypothetical
All-time return +41.17% S&P 500 +84.16%
vs. S&P 500 -42.99% behind the index

Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.

What Changed in Verition Fund Management's Axon Enterprise Position

Verition Fund Management reduced its stake in Axon Enterprise by 1,843 shares, leading to an 8.1% decrease in its holdings. The fund now holds 21,033 shares worth about $10.7 million, down from 22,876 shares previously.

Other Institutional Activity in Axon Enterprise

Elsewhere, BlackRock, Inc. reduced its holdings by 251,151 shares, now holding 7,989,186 shares valued at $3.39 billion, marking a 3% decrease. Vanguard Capital Management LLC opened a new position with 5,043,125 shares worth around $2.14 billion. State Street Corp increased its holdings by 131,605 shares to a total of 3,681,962 shares, valued at about $1.56 billion, reflecting a 3.7% increase. Baillie Gifford & Co also boosted its holdings by 817,149 shares, a 49.7% increase, ending with 2,459,727 shares worth $1.04 billion.

Axon Enterprise, Inc. Stock Down 6.7%

Shares of Axon Enterprise (NasdaqGS: AXON) traded near $510.60 on Tuesday. The company boasts a market cap of approximately $37.5 billion and a P/E ratio of 189. Its forward P/E stands at 44. Axon's stock has ranged from a 52-week low of $339.01 to a high of $885.92. The stock's 50-day moving average is $420.37, while the 200-day moving average is $537.25. Axon has a current ratio of 2.27 and a quick ratio of 1.70, with a debt-to-equity ratio of 52.07.

Year to date

$AXON stock price

Daily closing prices, year to date. Not investment advice.

Recent Earnings

Axon Enterprise reported revenue of $2.98 billion, with a growth rate of 33.7%. The company's earnings per share stood at $2.46, and it maintained a net margin of 6.9%. The return on equity was 6.8%. Axon is scheduled to release its next earnings report on August 3, 2026.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

F 27/100

Reported May 6, 2026

  1. Forward outlook

    4 target cuts vs 1 raises.

  2. EPS & revenue

    EPS missed estimates by 1.3%. Revenue beat estimates by 1.7%.

  3. Profit surprise

    EBITDA missed by 65 percent. Operating income missed by 69 percent.

  4. Pre-earnings setup

    Bar was high, analysts already very bullish.

  5. Analyst signal

    1 target raise, 4 target cuts.

  6. Earnings quality

    Gross margin down 1.5 points. Operating margin up 5.7 points. Positive free cash flow.

Earnings Call Summary

The quarter was the strongest ever for first quarter results, with revenue up 34 percent year over year to 807 million dollars. AI Era Plan bookings jumped 140 percent and Dedrone counter-drone business exploded up 500 percent, driven by demand across law enforcement, enterprise, and international markets. Management says they are at an inflection point where AI and connected devices are becoming essential infrastructure that customers want to deploy immediately, with nearly all large police agencies now including AI in their technology plans.

Guidance Axon expects full year revenue growth of 30 to 32 percent and raised that guidance from prior expectations. The company plans to spend about 450 million dollars on free cash flow this year and maintain 25.5 percent adjusted EBITDA margins. Management says AI adoption and counter-drone demand are accelerating faster than planned.

Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.

Insider Buying and Selling at Axon Enterprise, Inc.

Several insiders at Axon Enterprise sold shares recently. On June 5, 2026, President Joshua Isner sold 13,000 shares at an average price of $488.45. CEO Patrick Smith sold 20,000 shares on June 4, 2026, at $500 each, as part of a planned transaction. Chief Revenue Officer Cameron Brooks also sold 1,242 shares on the same day at $500, under a planned transaction. Additionally, Chief Human Officer Elizabeth Reid Coughlin sold 1,554 shares at $485 on June 4, 2026.

Analysts Set New Price Targets

On June 25, 2026, Citizens reiterated its buy rating for Axon Enterprise, setting a price target of $700. Earlier in May, Barclays maintained a buy rating with a $523 target, while UBS held a hold rating at $440. JP Morgan and Citizens also maintained their buy ratings, with targets of $755 and $700, respectively. Analysts have a consensus recommendation of 'buy' with a mean price target of $662.04.

About Axon Enterprise

Axon Enterprise, Inc., headquartered in Scottsdale, Arizona, provides public safety technology solutions worldwide. The company operates through two segments: Software and Services, and Connected Devices. It offers cloud-based software for managing digital evidence and develops hardware solutions like TASER devices and body cameras. Axon serves a broad range of clients, including government agencies and commercial enterprises.

Bottom Line

Verition Fund Management's reduction in Axon Enterprise holdings highlights ongoing institutional activity in the stock. Investors keep a close eye on these filings to gauge market sentiment, but it's important to remember that 13F filings are backward-looking and may not reflect the current position. Axon's diverse product offerings and analyst support suggest continued interest in its market performance.

Get Axon Enterprise, Inc. alerts

New 13F filings, insider trades, and analyst moves on $AXON, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.